Send to a Friend Share

Johnson & Johnson's (JNJ) Wins $1.67B Patent Verdict Versus Abbott Laboratories (ABT)

June 30, 2009 7:20 AM EDT
Centocor Ortho Biotech Inc., wholly-owned subsidiary of Johnson & Johnson (NYSE: JNJ), announced that a federal jury has returned a verdict of $1.67 billion against Abbott Laboratories (NYSE: ABT) in a patent infringement suit.

The patent in question relates to the company's anti-TNF class of arthritis treatments, and is co-owned by New York University and Centocor, for which Centocor is the exclusive licensee.

You May Also Be Interested In


Related Categories

Corporate News, Hot List

Related Entities

UBS

Add Your Comment





Follow StreetInsider.com On Twitter